Investors and Media
Press Releases
January 29, 2025
Scholar Rock Submits Biologics License Application (BLA) to the U.S. FDA for Apitegromab as a Treatment for Patients with Spinal Muscular Atrophy (SMA)
January 29, 2025
Scholar Rock Announces the Appointment of Industry Leader Lisa Wyman as Chief Technical and Quality Officer and Planned Leadership Transition
January 17, 2025
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 8, 2025
Scholar Rock Highlights 2025 Strategic Priorities
January 2, 2025
Scholar Rock to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 13, 2024
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 15, 2024
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 12, 2024
